Because increased weight (BMI) is associated with a greater risk of developing lymphedema 2 , weight management may also be indicated. Good educational information may be found in the literature 3 and at various web sites, including the National Lymphedema Network (NLN) risk reduction guidelines 4 and the American Cancer Society 5 .
A recent study reported that breast cancer patients who were educated about the risks for developing lymphedema developed fewer symptoms and practiced more risk reduction behaviors (such as avoiding blood pressure readings, blood draws, and injections on the affected limb), than those who did not receive educational information 6 .
Although not always the case, it is highly recommended that the standard of care
include an initial patient consultation with a professional skilled in lymphedema therapy and education, either prior to surgery or soon after, in order to improve patient outcomes.
Early Detection
It is well known that lymphedema, left untreated, will progressively become worse 7 . The earlier lymphedema is detected and properly treated, the better will be the Thus, there have been efforts to help practitioners identify latent or incipient lymphedema using more quantitative methods, including the detection of early tissue changes by electrical impedance [9] [10] [11] , changes in limb volume 12 via circumferential measurement, or changes in tissue dielectric constant values measured anywhere on the body surface [13] [14] [15] . Although promising, these approaches are limited by the absence of accepted, standard criteria for pre-clinical lymphedema. Additionally, the patient must be evaluated at the lymphedema clinic, preferably prior to surgery, and at follow-up intervals after surgery if pre-clinical lymphedema is to be readily detected. Again, this emphasizes the importance of early pre-surgical consultation and evaluation which is beginning to be recognized and implemented 16 as standard of care.
Phase I: In-Clinic Decongestive Therapy
Once lymphedema is detected, patients are usually referred to a lymphedema clinic staffed by certified, trained lymphedema therapists. This intensive, short-term therapy is known as Complete Decongestive Physiotherapy (CDP) (or Complex Decongestive Therapy, CDT). The goals of CDP are to: (1) arrest disease progression;
(2) reduce lymphedema volume; (3) prevent infections; (4) restore mobility and range of motion; and (5) train patients for life-long, self-management of the condition at home. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 [20] [21] [22] [23] .
The MLD component is used to move lymph fluid out of affected lymphedematous regions to more centrally located healthy regions, thereby reducing edema volume. Exercise constructively influences lymph flow through body movement and transient muscle contraction, particularly when combined with SSCB. The use of SSCB also serves to sustain the reduced volume until the next MLD treatment in part by decreasing the transcapillary ultrafiltration rate. The short-stretch nature of the specific bandages used for lymphedema treatment is significant. Short-stretch bandage material has few elastic fibers and will stretch less than a material with many elastic fibers (longstretch). During transient muscle contraction, the reduced expansion of the bandage creates resistance resulting in high sub-bandage dynamic or "working pressure". This is illustrated in Figure 1 when a patient squeezes a rubber ball. Such dynamic pressures are transmitted inward making fibrotic tissue softer while simultaneously facilitating fluid movement by its effects on interstitial space contents and lymphatic vessel activation.
With short-stretch bandages large functional dynamic pressures can be achieved with low resting pressures thereby helping to prevent circulatory compromise, especially important in patients with vascular deficiencies . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   7 Because MLD is central to the Phase I therapeutic processes, and self-MLD and/or IPC is used in Phase II, the following discussion will consider the physiological basis for successful application of these therapies in upper extremity lymphedema.
The lymphatic system consists of an enormous number of lymphatic vessels, punctuated with lymph glands (nodes). Movement of lymph fluid through these vessels is directed toward specific entry points into the venous system. For drainage of the upper extremity under normal healthy conditions (Figure 2A If nodes are removed, or lymphatic channels damaged by radiation (e.g., as part of breast cancer treatment), then the ability of upper-extremity lymphatic channels and all truncal tributaries to move lymph out of their respective territories is reduced ( Figure   2B ). This reduction depends on the number of lymph nodes impacted, their prior share of the overall drainage load, and other effects associated with surgery and radiation.
Subsequent effects depend on the extent of lymphatic channels with direct connections to the venous system, the presence of anastomotic lymph collectors connecting the affected quadrant to the contralateral axillary and supraclavicular nodes, and on differences of upper extremity lymph-flow features that affect subsequent arm lymphedema patterns. If the reduction in lymph drainage capacity is large enough, lymphedema develops. . The effectiveness of both MLD and IPC depends on stimulating lymphatic flow in a way that facilitates lymph movement through alternative pathways, so that lymph is moved from lymphedematous regions circumventing damaged normal pathways. Key to effective therapy is the recognition of the underlying physiological processes, anatomical features and physical principles governing the lymph movement. Collectively, these underscore the importance of treating the truncal lymphatics for effective lymphedema therapy.
Lymph movement within and then out of lymphatic territories is determined by: (1) normal contractile activity of lymphatic vessels; (2) 24, 26 . Phase I care concludes when the therapist determines that the patient has attained the maximum benefit to be achieved by the intensive treatment. (i.e. a plateau has been reached) The optimal outcome is a near normalization of the affected limb in terms of limb volume, tissue health, pain reduction and improved range of motion and mobility. During the final stages of Phase I, the therapist will focus on educating and training the patient in the techniques necessary to achieve effective long term management in the home.
Phase II: Self-Management at Home
In Phase II, the patient assumes responsibility for maintaining or improving the clinical results achieved in Phase I, and managing the condition long-term at home by reducing the risks of exacerbations and associated complications. Self management in the home includes the following: (1) self-MLD; (2) skin care; (3) self-examination to detect signs of infection; (4) appropriate fitting and consistent wear and care of compression garments, bandages or alternative compression systems; (5) weight control, and exercise; and in many cases (6) use of an IPC device.
Poor patient compliance in performing home self-care is a major factor contributing to the loss of gains so diligently achieved during Phase I 21 . Such losses (and in fact reversals) may trigger complications, including fibrosis, inflammation, cellulitis, diminished range of motion and pain. Lack of compliance, especially with respect to self-MLD and bandaging, may be attributable to a number of factors. The affected areas may be difficult to reach because of impaired mobility, or because of their location (e.g., the backside). The location of the affected area also complicates application of compression bandaging, which can be more difficult to apply to the trunk than to the extremities.
Further, self-care is emotionally challenging because of the daily time required. Self-MLD is physically demanding and requires the patient's complete attention. These demands are becoming more difficult to meet in light of the longevity of cancer survivors and their declining physical prowess. To be effective, self-MLD must also be done consistently and correctly, which for many patients is a significant challenge. This selfcare regimen may also lead to repetitive stress injuries of the already compromised limb or unaffected limb.
Together these factors can impede compliance, particularly as the patients may be coping with cancer and its aftermath. As a result, many patients who initially make diligent efforts to adhere to the in-home treatment regimen experience exacerbations of the lymphedema or related infections, and require further rounds of in-clinic treatment, including CDP. While the therapist's specialized attention is often psychologically supportive to the patient, the costs associated with cycling through multiple sessions of professionally administered CDP continue to mount. Some third-party payers do not cover repeated CDP sessions, creating a financial burden for the patient. The use of advanced, programmable IPC devices provides an effective treatment approach that can ease the physical and emotional burdens of self-care [27] [28] [29] [30] .
In considering IPC use for lymphedema treatment it is important to define a minimum set of device features required to provide safe and effective therapy consistent with underlying physiological principles. (unpublished, data available on request), their greatest concerns about using or recommending IPC was that it would cause truncal or genital edema or produce fibrotic cuffs. Each of these is a concern with simple 'older generation' pumps that do not provide truncal clearance. . Therefore the clinicians' ability to prescribe appropriate therapy is impeded 
Risks and Complications of Ineffective Therapy
Lymphedema is a chronic condition that without effective treatment progressively grows worse . Patients may also report discomfort with movement and difficulty performing 
Summary
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